Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
6.67
+0.09 (1.37%)
Apr 24, 2025, 12:13 PM EDT - Market open
Kamada Market Cap
Kamada has a market cap or net worth of $380.09 million as of April 24, 2025. Its market cap has increased by 22.02% in one year.
Market Cap
380.09M
Enterprise Value
312.39M
1-Year Change
22.02%
Ranking
Category
Stock Price
$6.67
Market Cap Chart
Since May 31, 2013, Kamada's market cap has increased from $346.50M to $380.09M, an increase of 9.69%. That is a compound annual growth rate of 0.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 378.40M | 8.08% |
| Dec 31, 2024 | 350.10M | 27.59% |
| Dec 29, 2023 | 274.40M | 52.78% |
| Dec 30, 2022 | 179.60M | -38.99% |
| Dec 31, 2021 | 294.40M | 12.58% |
| Dec 31, 2020 | 261.50M | -4.98% |
| Dec 31, 2019 | 275.20M | 36.71% |
| Dec 31, 2018 | 201.30M | 16.29% |
| Dec 29, 2017 | 173.10M | -12.80% |
| Dec 30, 2016 | 198.50M | 33.04% |
| Dec 31, 2015 | 149.20M | 9.22% |
| Dec 31, 2014 | 136.60M | -73.22% |
| Dec 31, 2013 | 510.10M | 47.22% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.28B |
| UnitedHealth Group | 388.73B |
| Johnson & Johnson | 372.68B |
| AbbVie | 318.28B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.25B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |